Francesca Galvani
Parma, 43124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
N-Acylaminoethyltetrahydroquinolines: A new class of melatonin receptor ligands with in vivo activity on glioblastoma.
Journal: European journal of medicinal chemistry
Published: August 11, 2025
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations.
Journal: Journal of chemical information and modeling
Published: January 17, 2025
Protective Activity of Melatonin Combinations and Melatonin-Based Hybrid Molecules in Neurodegenerative Diseases.
Journal: Journal of pineal research
Published: June 27, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies.
Journal: ACS pharmacology & translational science
Published: April 09, 2024
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.
Journal: Biochemical pharmacology
Published: January 10, 2024
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity.
Journal: Journal of chemical information and modeling
Published: November 01, 2023
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
Journal: Scientific reports
Published: October 05, 2023
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.
Journal: Journal of chemical information and modeling
Published: April 13, 2023
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents.
Journal: Journal of chemical information and modeling
Published: February 10, 2023
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach.
Journal: Biochemical pharmacology
Published: December 01, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions.
Journal: European journal of medicinal chemistry
Published: October 14, 2022
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency.
Journal: Journal of chemical information and modeling
Published: May 17, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026